SOPHARMA AD - Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.

Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:

1. Donev_SopharmaWarrants_EN_14122023.pdf Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.
   

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 234 / 2023

Date of issue: 2023-12-15

Short name of the issuer

SOPHARMA AD

Subject

Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.

Official market - legal basis

art. 56. 1. 2 of Act on Public Offering.

Unofficial market - legal basis

Contents of the report:

Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.

Annexes

File Description

Donev_SopharmaWarrants_EN_14122023.pdfDonev_SopharmaWarrants_EN_14122023.pdf Notification from Ognian Donev under Art. 19 of Regulation (EU) № 596/2014 of the European Parliament and of the Council of April 16, 2014 from 14 December 2023.

SOPHARMA AD

(fullname of the issuer)

SOPHARMA AD Farmaceutyczny (far)

(short name of the issuer) (sector according to clasification of the WSE in Warsow)

1220 Sofia

(post code) (city)

IlienskoShosse 16

(street) (number)

[phone] [phone]

(phone number) (fax)

(e-mail) (web site)

nd

(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Date Name Position / Function Signature

2023-12-15 Ognian Donev Executive Director